EMGE Emergent Health Corp (PK)

Emergent Health Corp. (Other OTC:EMGE) announces it has increased its revenues from first half of 2008 to first half of 2009 by 82%, producing an unaudited net profit of $0.001 per share before taxes. Continued progress is anticipated and based upon it reaching the $100,000,000 sales mark at some point in the future, plus maintaining its current profit margin, profits of up to $20,000,000 could be achievable with appropriate capital and market penetration. This is also based upon the current market for products that increase adult stem cells through prescription already being in excess of $4 Billion with AMGEN; symbol AMGN, being the leader.

Emergent’s goal is to develop products that mimic the body’s own method to accomplish a positive biochemical event. Vita-Stim™ Stem Cell Nutrition is our patented cutting edge product in this space. http://www.vita-stim.com

Emergent is a multi-specialty Biotechnology Company focused on advanced scientific research to discover, develop, innovate and commercialize patented/patentable human products for the field of Regenerative Medicine. This includes enhanced phytochemical formulations for mass markets not requiring a prescription and having proper third party labeling. Emergent has proprietary anti-aging, weight loss and pain relief products in its pipeline. http://www.emergenthealth.com

Emergent also has future plans to become a fully reporting company. Form D was filed with the Securities and Exchange Commission this month.

This press release contains certain "forward-looking" statements, as defined in the United States Private Securities Litigation Reform Act of 1995 that involve a number of risks and uncertainties. Statements, which are not historical facts, are forward-looking statements. The company, through its management, makes forward-looking public statements concerning its expected future operations, performance and other developments. Such forward-looking statements are estimates reflecting the company's best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. It is impossible to identify all such factors, factors that could cause actual results to differ materially from those estimated by the company.

This press release is provided for information purposes only and is not intended to constitute an offer to sell or a solicitation of an offer to buy securities.

Emergent Health (PK) (USOTC:EMGE)
Historical Stock Chart
Von Nov 2024 bis Dez 2024

Emergent Health (PK) (USOTC:EMGE)
Historical Stock Chart
Von Dez 2023 bis Dez 2024